FZD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.652000E-01
Normal-vs-Stage2
7.279600E-01
Normal-vs-Stage3
6.603200E-01
Normal-vs-Stage4
6.283600E-01
Stage1-vs-Stage2
4.826200E-01
Stage1-vs-Stage3
6.351400E-01
Stage1-vs-Stage4
3.803400E-01
Stage2-vs-Stage3
3.660800E-01
Stage2-vs-Stage4
5.787400E-01
Stage3-vs-Stage4
3.523400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.918800E-01
Normal-vs-AfricanAmerican
9.349200E-01
Normal-vs-Asian
6.904000E-01
Caucasian-vs-AfricanAmerican
7.974200E-01
Caucasian-vs-Asian
6.032200E-01
AfricanAmerican-vs-Asian
6.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.319400E-01
Normal-vs-Female
6.805400E-01
Male-vs-Female
4.664400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.393600E-01
Normal-vs-Age(41-60Yrs)
4.851800E-01
Normal-vs-Age(61-80Yrs)
9.609600E-01
Normal-vs-Age(81-100Yrs)
8.991400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.141000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.097400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.505600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.519800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.826400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.908200E-01
Normal-vs-Daily Drinker
9.629800E-01
Normal-vs-Weekly Drinker
9.377400E-01
Normal-vs-Occasional Drinker
3.356400E-01
Normal-vs-Social Drinker
9.366400E-01
Non Drinker-vs-Daily Drinker
8.279800E-01
Non Drinker-vs-Weekly Drinker
6.376000E-01
Non Drinker-vs-Occasional Drinker
4.376300E-02
Non Drinker-vs-Social Drinker
8.958400E-01
Daily Drinker-vs-Weekly Drinker
8.302000E-01
Daily Drinker-vs-Occasional Drinker
3.402400E-02
Daily Drinker-vs-Social Drinker
9.491400E-01
Weekly Drinker-vs-Occasional Drinker
2.691900E-02
Weekly Drinker-vs-Social Drinker
7.842000E-01
Occasional Drinker-vs-Social Drinker
6.907500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.982350E-01
Normal-vs-Grade 2
5.610100E-02
Normal-vs-Grade 3
4.819700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.039500E-02
Grade 1-vs-Grade 3
1.201280E-03
Grade 1-vs-Grade 4
1.982350E-01
Grade 2-vs-Grade 3
4.472300E-02
Grade 2-vs-Grade 4
5.610100E-02
Grade 3-vs-Grade 4
4.819700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.447200E-01
Normal-vs-NonDiabetic
7.469600E-01
Diabetic-vs-NonDiabetic
1.354210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.161800E-01
Normal-vs-NoPancreatitis
8.036000E-01
Pancreatitis-vs-NoPancreatitis
7.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.134800E-01
Normal-vs-N1
7.046200E-01
N0-vs-N1
3.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.295600E-01
Normal-vs-TP53-NonMutant
7.420200E-01
TP53-Mutant-vs-TP53-NonMutant
2.85669999999794E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
